Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Jan 28;173(2):113-21.
doi: 10.1001/2013.jamainternmed.987.

Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial

Jun Ma  1 , Veronica Yank, Lan Xiao, Philip W Lavori, Sandra R Wilson, Lisa G Rosas, Randall S Stafford
Affiliations
Randomized Controlled Trial

Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial

Jun Ma et al. JAMA Intern Med. .

Abstract

Background: The Diabetes Prevention Program (DPP) lifestyle intervention reduced the incidence of type 2 diabetes mellitus (DM) among high-risk adults by 58%, with weight loss as the dominant predictor. However, it has not been adequately translated into primary care.

Methods: We evaluated 2 adapted DPP lifestyle interventions among overweight or obese adults who were recruited from 1 primary care clinic and had pre-DM and/or metabolic syndrome. Participants were randomized to (1) a coach-led group intervention (n = 79), (2) a self-directed DVD intervention (n = 81), or (3) usual care (n = 81). During a 3-month intensive intervention phase, the DPP-based behavioral weight-loss curriculum was delivered by lifestyle coach-led small groups or home-based DVD. During the maintenance phase, participants in both interventions received lifestyle change coaching and support remotely-through secure email within an electronic health record system and the American Heart Association Heart360 website for weight and physical activity goal setting and self-monitoring. The primary outcome was change in body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) from baseline to 15 months.

Results: At baseline, participants had a mean (SD) age of 52.9 (10.6) years and a mean BMI of 32.0 (5.4); 47% were female; 78%, non-Hispanic white; and 17%, Asian/Pacific Islander. At month 15, the mean ± SE change in BMI from baseline was -2.2 ± 0.3 in the coach-led group vs -0.9 ± 0.3 in the usual care group (P < .001) and -1.6 ± 0.3 in the self-directed group vs usual care (P = .02). The percentages of participants who achieved the 7% DPP-based weight-loss goal were 37.0% (P = .003) and 35.9% (P = .004) in the coach-led and self-directed groups, respectively, vs 14.4% in the usual care group. Both interventions also achieved greater net improvements in waist circumference and fasting plasma glucose level.

Conclusion: Proven effective in a primary care setting, the 2 DPP-based lifestyle interventions are readily scalable and exportable with potential for substantial clinical and public health impact.

Trial registration: clinicaltrials.gov Identifier: NCT00842426.

PubMed Disclaimer

Conflict of interest statement

Dr. Stafford reports that he has provided consulting services to Mylan Pharmaceuticals in the past. The remaining authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Screening, Randomization, and Assessments of Study Participants
Figure 2
Figure 2
Estimated Mean (±SE) Weight Change over a 15-Month Period in the Intention-to-Treat Population, Overall and by Sex
Figure 3
Figure 3
Categorical Weight Loss at 6 and 15 Months in the Intention-to-Treat Population
See this image and copyright information in PMC

Comment in

  • Obesity: finding weight loss strategies that work in primary care.
    Wilson C. Wilson C. Nat Rev Endocrinol. 2013 Mar;9(3):126. doi: 10.1038/nrendo.2012.244. Epub 2013 Jan 8. Nat Rev Endocrinol. 2013. PMID: 23296170 No abstract available.
  • Efficacy vs effectiveness.
    Pagoto SL, Lemon SC. Pagoto SL, et al. JAMA Intern Med. 2013 Jul 8;173(13):1262-3. doi: 10.1001/jamainternmed.2013.6521. JAMA Intern Med. 2013. PMID: 23836268 No abstract available.
  • Efficacy vs effectiveness--reply.
    Ma J, Kramer MK, Ciechanowski P. Ma J, et al. JAMA Intern Med. 2013 Jul 8;173(13):1263-4. doi: 10.1001/jamainternmed.2013.7065. JAMA Intern Med. 2013. PMID: 23836269 No abstract available.

References

    1. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012 Feb 1;307(5):491–497. - PubMed
    1. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003 Jan 7;138(1):24–32. - PubMed
    1. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 2009 Sep-Oct;28(5):w822–831. - PubMed
    1. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997 Apr;20(4):537–544. - PubMed
    1. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001 May 3;344(18):1343–1350. - PubMed

Publication types

Associated data